Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014
about
Molecular Basis of Alcohol-Related Gastric and Colon CancerChanges in standardized mortality rates from thyroid cancer in Korea between 1985 and 2015: Analysis of Korean national data.Strategies for Appropriate Patient-centered Care to Decrease the Nationwide Cost of Cancers in KoreaStress and Depressive Symptoms in Cancer Survivors and Their Family Members: Korea Community Health Survey, 2012.Association Between Health Behaviors and Family History of Cancer in Cancer Survivors: Data From the Korean Genome and Epidemiology Study.Second Primary Cancer Screening: Role of the Primary Care Physician.External Validation of a Gastric Cancer Nomogram Derived from a Large-volume Center Using Dataset from a Medium-volume Center.Prognostic value of c-Met overexpression in pancreatic adenocarcinoma: a meta-analysis.The addition of bevacizumab in the first-line treatment for metastatic colorectal cancer: an updated meta-analysis of randomized trials.MET inhibitors in advanced non-small-cell lung cancer: a meta-analysis and review.Apoptotic and antiproliferative properties of 3β-hydroxy-Δ5-steroidal congeners from a partially purified column fraction of Dendronephthya gigantea against HL-60 and MCF-7 cancer cells.Prognostic value of smoking status in non-small-cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis.Dietary supplement use among cancer survivors and the general population: a nation-wide cross-sectional study.Clinicopathological impacts of high c-Met expression in renal cell carcinoma: a meta-analysis and review.The role of anti-EGFR agents in patients with locoregionally advanced head and neck cancer: a meta-analysis of randomized trials.Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.Treatment Patterns and Outcomes in Elderly Patients with Metastatic Breast Cancer: A Multicenter Retrospective Study.The role of anti-EGFR agents in the first-line treatment of advanced esophago-gastric adenocarcinoma: a meta-analysis.Molecular targeted agents as second-line treatment for hepatocellular carcinoma: a meta-analysis and review.Prognostic value of c-Met overexpression in hepatocellular carcinoma: a meta-analysis and review.Survival benefit of anti-angiogenic agents in patients with previously treated advanced gastric or gastroesophageal junction cancer: a meta-analysis.Active Surveillance of Papillary Thyroid Microcarcinoma: A Mini-Review from Korea.Occupational radiation exposure and its health effects on interventional medical workers: study protocol for a prospective cohort study.Cancer incidence in northern Thailand: Results from six population-based cancer registries 1993-2012.A psychological intervention programme for patients with breast cancer under chemotherapy and at a high risk of depression: A randomised clinical trial.Vitamin D Deficiency Associated with Differentiated Thyroid Carcinoma: A Case- Control StudyThe Prognostic Impact of the Number of Metastatic Lymph Nodes and a New Prognostic Scoring System for Recurrence in Early-Stage Cervical Cancer with High Risk Factors: A Multicenter Cohort Study (KROG 15-04).Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer.Second primary cancer after liver transplantation in hepatocellular carcinoma: a nationwide population-based study.Thyroid function after TSH suppression for thyroid cancer: When is optimal time to check?Changes in Clinical Characteristics of Patients with an Initial Diagnosis of Prostate Cancer in Korea: 10-Year Trends Reported by a Tertiary Center.A national survey of lung cancer specialists' views on low-dose CT screening for lung cancer in Korea.Clinicopathological impacts of high c-Met expression in head and neck squamous cell carcinoma: a meta-analysis and review.Sequential spinal and intracranial dural metastases in gastric adenocarcinoma: A case report.Does breast density measured through population-based screening independently increase breast cancer risk in Asian females?The Correlation Between Serum Chemokines and Clinical Outcome in Patients with Advanced Biliary Tract Cancer.Interaction between physical activity, PITX1 rs647161 genetic polymorphism and colorectal cancer risk in a Korean population: a case-control study.Galanin is an epigenetically silenced tumor suppressor gene in gastric cancer cells.Budget Impact of the Accreditation Program for Clinical Laboratories on Colorectal Cancer Screening via Fecal Immunochemical Testing: Results from the National Cancer Screening Program in Korea.Successful Robotic Gastrectomy Does Not Require Extensive Laparoscopic Experience.
P2860
Q33838371-98BABF93-B173-4FB9-A231-41DBFF14F834Q38620184-4F2B790E-3EDB-4E75-99A8-8C37E629192DQ41224696-0DF83F88-CA7E-4BC2-9306-AA23699C631BQ41659944-0F54B9F3-A803-4376-A542-2BA53F9BC9BBQ42287110-E9095BC9-D23E-4392-94F2-E553242BB6B5Q42344530-7D300070-F67A-4299-8295-DCEF895B6218Q42366478-B15F8570-3862-4839-8B19-26FFFAF8ECE7Q42700697-E0900352-8A32-49F4-B7FA-764C70D4CEECQ42700710-61018150-DE1A-4F5F-9010-987C52E52F4AQ45968290-AB3045AF-C14B-429A-8D0A-8E568F16AC4DQ46260580-2EF6B463-FA92-4A14-814F-95837B8A8741Q47094413-7B477AF8-09D7-43F7-A8DE-BA03CAE67ED7Q47097574-0236FCF6-0F63-48F5-B07F-4B4A4AA11B63Q47103399-158FE17B-E828-4180-8CFF-403D4896FA50Q47103766-BEE8A74E-44B4-4516-857D-7F849D32CC3FQ47110234-D405C4C7-30C6-44DF-8B6E-388C23123CCAQ47110699-CC1707FE-849C-4D3A-8974-DE8C5AFF686EQ47120612-8A8E956B-44E3-49A8-AAA7-90EA41999E03Q47121307-64E69299-9538-4834-863C-34446327AD97Q47139946-97E9BB9D-D881-48A9-B605-2F058C417900Q47149532-5F9D02E2-5CC7-4CAB-A66C-BBB78170F706Q47154732-E71EAF91-2091-40D5-AFF9-C55589F5AAB7Q47191265-7CBA7DA3-42FF-453A-922C-C24A66CC5B9CQ47333184-A0EA23B5-4591-4CC1-965D-736444DBEAFDQ47361506-59BAF4B0-6694-4145-9C13-06D028A4A5BBQ47559277-B245F442-181F-455B-987A-14CAB6FAC221Q47695956-A794E43E-D449-43C1-BEBA-38B806E51ADDQ47712300-6F367C04-3E2D-4F9F-9651-09D3963E5C17Q47853149-33CE342D-84A1-4944-9D72-2654DA73F8DBQ48144422-DBE6D031-837A-4776-A569-7BCA08B22FA3Q48210796-C7075B71-3D40-4B08-8342-ECABE42E04D5Q48499216-55905EF4-F44A-4063-A463-A9EC39BB22D9Q49414583-459F4D1B-41A6-4ADB-A8B2-B299C959E82DQ49541387-6638E025-D43D-43DB-B36B-A5424F5C2108Q49725262-7F167FC3-37F0-462D-9480-3FC06438287CQ49967651-170B268E-B6FF-4D6C-B2F5-CEA72A5F140CQ50328827-4D6EEE4E-2F8A-441B-8A7F-EEADAF59A977Q51749781-B4C28A03-A475-41F7-9103-3630B5DADCC8Q51755260-DA6BB810-40F4-462E-B35E-AA65A6616004Q52599487-5A10AA49-6BC4-48EB-A1AB-3CB01D52804F
P2860
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014
@ast
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014
@en
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014.
@nl
type
label
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014
@ast
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014
@en
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014.
@nl
prefLabel
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014
@ast
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014
@en
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014.
@nl
P2093
P2860
P356
P1476
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014
@en
P2093
Chang-Mo Oh
Community of Population-Based Regional Cancer Registries
Duk Hyoung Lee
Hyun-Joo Kong
Kang Hyun Lee
Kyu-Won Jung
Young-Joo Won
P2860
P304
P356
10.4143/CRT.2017.118
P577
2017-03-09T00:00:00Z